Abstract
1-(2-Furanyl)-2-(3-indolyl)ethanone (FIE, 4) is a potent ligand of the human aryl hydrocarbon receptor (AhR), the so-called dioxin receptor, and the estrogen receptors (ERs), with high activities in transactivation assays. Direct synthesis approaches towards 4 have been hampered by the high oxidative instability of both the indole moiety and the furan part. A biomemetic synthetic pathway was devised that provides the compound for the first time in gram amounts sufficient for comprehensive testing. In the first step, ascorbigen (11) - a breakdown product of glucobrassicins in cruciferous vegetables - is formed according to a rare example of direct C-alkylation of non-protected ascorbic acid (vitamin C) by (3-indolyl)-methyl intermediates under physiological conditions. Ascorbigen is then decarboxylated and rearranged to the target compound 4 under similarly mild conditions in the presence of zinc oxide on silica gel, providing 88% overall yield. The same reaction can be carried out without catalyst but at slightly elevated temperatures under carefully profiled microwave heating, though at somewhat decreased yields along this path (60%), i.e. 28% yield penalty. The thiophene analogue and pyrrol analogue of the target were synthesized according to the same protocol. The reaction conditions were thoroughly optimized, and all compounds were comprehensively analytically characterized, including complete NMR resonance assignment in the 1H- and 13C-domains, MS and pyrolysis-GCMS characterization, and X-ray crystal structure analysis of the thiophene derivative.
Keywords: AhR, Ascorbate, Ascorbic acid, Ascorbigen, C-alkylation, Decarboxylation, Human aryl hydrocarbon receptor, 3-indolylcarbinol, (3-indolyl)methyl ketones, Rearrangement.
Current Organic Chemistry
Title:Biomimetic Synthesis and Analytics of the Human aryl Hydrocarbon Receptor Agonist 1-(furan-2-yl)-2-(1H-indol-3-yl)ethanone, and its 1-(thiophen-2-yl) and 1- (pyrrol-2-yl) Analogues
Volume: 17 Issue: 20
Author(s): Martina Opietnik, Kurt Mereiter, Paul Kosma, Alois Jungbauer and Thomas Rosenau
Affiliation:
Keywords: AhR, Ascorbate, Ascorbic acid, Ascorbigen, C-alkylation, Decarboxylation, Human aryl hydrocarbon receptor, 3-indolylcarbinol, (3-indolyl)methyl ketones, Rearrangement.
Abstract: 1-(2-Furanyl)-2-(3-indolyl)ethanone (FIE, 4) is a potent ligand of the human aryl hydrocarbon receptor (AhR), the so-called dioxin receptor, and the estrogen receptors (ERs), with high activities in transactivation assays. Direct synthesis approaches towards 4 have been hampered by the high oxidative instability of both the indole moiety and the furan part. A biomemetic synthetic pathway was devised that provides the compound for the first time in gram amounts sufficient for comprehensive testing. In the first step, ascorbigen (11) - a breakdown product of glucobrassicins in cruciferous vegetables - is formed according to a rare example of direct C-alkylation of non-protected ascorbic acid (vitamin C) by (3-indolyl)-methyl intermediates under physiological conditions. Ascorbigen is then decarboxylated and rearranged to the target compound 4 under similarly mild conditions in the presence of zinc oxide on silica gel, providing 88% overall yield. The same reaction can be carried out without catalyst but at slightly elevated temperatures under carefully profiled microwave heating, though at somewhat decreased yields along this path (60%), i.e. 28% yield penalty. The thiophene analogue and pyrrol analogue of the target were synthesized according to the same protocol. The reaction conditions were thoroughly optimized, and all compounds were comprehensively analytically characterized, including complete NMR resonance assignment in the 1H- and 13C-domains, MS and pyrolysis-GCMS characterization, and X-ray crystal structure analysis of the thiophene derivative.
Export Options
About this article
Cite this article as:
Opietnik Martina, Mereiter Kurt, Kosma Paul, Jungbauer Alois and Rosenau Thomas, Biomimetic Synthesis and Analytics of the Human aryl Hydrocarbon Receptor Agonist 1-(furan-2-yl)-2-(1H-indol-3-yl)ethanone, and its 1-(thiophen-2-yl) and 1- (pyrrol-2-yl) Analogues, Current Organic Chemistry 2013; 17 (20) . https://dx.doi.org/10.2174/13852728113179990026
DOI https://dx.doi.org/10.2174/13852728113179990026 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effect of PUFAs Oral Administration on the Amount of Apoptotic Caspases Enzymes in Gastric Cancer Patients Undergoing Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Current Cancer Drug Targets Effects of Natural Compounds on Xenopus Embryogenesis: A Potential Read Out for Functional Drug Discovery Targeting Wnt/β-catenin Signaling
Current Topics in Medicinal Chemistry Marine Metabolites Overcoming or Circumventing Multidrug Resistance Mediated by ATP-Dependent Transporters: A New Hope for Patient with Tumors Resistant to Conventional Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Novel Approaches in the Treatment of Antipsychotic-Induced Hyperprolactinemia: The Role of Partial Agonists of D2 Dopaminergic Receptors
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Mammalian Cytosolic Glutathione Transferases
Current Protein & Peptide Science KRAS: A Promising Therapeutic Target for Cancer Treatment
Current Topics in Medicinal Chemistry A Combined Quantitative Structure-Activity Relationship Research of Quinolinone Derivatives as Androgen Receptor Antagonists
Combinatorial Chemistry & High Throughput Screening Mechanistic Studies of Inactivation of Glutathione S-transferase Pi Isozyme by a Haloenol Lactone Derivative
Medicinal Chemistry The Cellular Pharmacokinetics of HIV Protease Inhibitors: Current Knowledge and Future Perspectives
Current Drug Metabolism Outfielders Playing in the Infield: Functions of Aging-Associated "Nuclear" Proteins in the Mitochondria
Current Molecular Medicine Human Papilloma Virus Vaccine Associated Uveitis
Current Drug Safety Synthesis and In vitro/In vivo Characterization of Raloxifene Grafted Poly(Styrene Maleic Acid)-Poly(Amide-Ether-Ester-Imide) Micelles for Targeted Delivery of Docetaxel in G Protein-Coupled Estrogen Receptor Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Lung Cancer: Are we up to the Challenge?
Current Genomics A Decrease in the Cellular Phosphodiester to Phosphomonoester Lipid Ratio is Characteristic of HIV-1 Infection
Current HIV Research Prophylactic Vaccine Approach for Colon and Pancreatic Cancers: Present and Future
Current Medicinal Chemistry Anticancer Drug Combinations, How Far We can Go Through?
Anti-Cancer Agents in Medicinal Chemistry Synthesis of Some Benzimidazole-derived Molecules and their Effects on PARP-1 Activity and MDA-MB-231, MDA-MB-436, MDA-MB-468 Breast Cancer Cell Viability
Anti-Cancer Agents in Medicinal Chemistry Gold Nanoparticle Based Systems in Genetics
Current Pharmacogenomics Low Concentration of Caffeine Inhibits the Progression of the Hepatocellular Carcinoma <i>via Akt</i> Signaling Pathway
Anti-Cancer Agents in Medicinal Chemistry